Experience

Rick Jantz

    • X4 Pharmaceuticals in its Exclusive License Agreement with Abbisko Therapeutics 


    • GENFIT SA in its Licensing and Collaboration Agreement with Terns Pharmaceuticals 


    • Vir Biotechnology - $143 Million IPO 


    • Arlo to Partner with Verisure 


    • Reata Pharmaceuticals – $505 Million Follow-On Offering 


    • Synthorx to Sell to Sanofi for $2.5 Billion 


    • Vivid Cortex Sells to SolarWinds  


    • DocuSign to Acquire AI Technology Provider Seal Software